Inoxgen

Nitric Oxide, the active ingredient in Inoxgen, is a vasodilator presented as a medical gas for endotracheopulmonary (inhalation) use. It is employed to treat pulmonary hypertension in neonates and adults, as well as right ventricular dysfunction.\n\nGNH India supplies Inoxgen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Inoxgen acts on the pulmonary vasculature to lower arterial pressure in specific disease states.\n\nNeonatal pulmonary hypertension: improves oxygenation and reduces pulmonary arterial pressure.\nAdult pulmonary hypertension: decreases right‑ventricular afterload and enhances exercise capacity.\nRight ventricular dysfunction: alleviates pulmonary vascular resistance, supporting right‑heart function.

Inoxgen may cause a range of adverse reactions that vary in frequency and severity.\n\nCommon Side Effects:\n- Methemoglobinemia: elevation of methemoglobin levels causing reduced oxygen delivery.\n- Nitrogen dioxide formation: irritant gas that can damage airway mucosa.\n- Systemic hypotension: transient drop in systemic blood pressure.\n- Rebound pulmonary hypertension: increase in pressure after abrupt discontinuation.\n- Cough or throat irritation: mild upper airway discomfort.\n\nSerious or Rare Side Effects:\n- Severe hypotension leading to organ hypoperfusion.\n- Hemorrhage: increased bleeding tendency, especially with anticoagulants.\n- Platelet dysfunction: impaired aggregation and clot formation.\n- Renal impairment: worsening kidney function in susceptible patients.\n- Acute respiratory distress: rare severe lung injury.

When using Inoxgen, clinicians should consider several safety measures.\n\nDose titration: adjust based on continuous hemodynamic monitoring.\nMonitoring methemoglobin: regularly check blood levels to avoid toxicity.\nAvoid abrupt discontinuation: taper to prevent rebound pulmonary hypertension.\nConcurrent vasodilators: use cautiously with other agents that lower blood pressure.\nPregnancy and lactation: assess risk‑benefit, as safety data are limited.\nStore at ambient temperature: keep cylinders upright, protected from heat, direct sunlight, and ensure proper ventilation.

Inoxgen can interact with other medications that affect vascular tone or blood components.\n\nMajor Interactions (Avoid):\n- Phosphodiesterase‑5 inhibitors (e.g., sildenafil): may cause profound hypotension.\n- Other nitric‑oxide donors: additive vasodilatory effect leading to severe blood pressure drop.\n\nModerate Interactions (Monitor Closely):\n- Anticoagulants (e.g., warfarin, heparin): increased risk of bleeding.\n- Inhaled anesthetics (e.g., sevoflurane): may potentiate hypotensive response.\n- Antiplatelet agents (e.g., aspirin, clopidogrel): monitor for platelet dysfunction.